News headlines about R1 RCM (NYSE:RCM) have been trending somewhat positive recently, Accern reports. The research group scores the sentiment of media coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. R1 RCM earned a media sentiment score of 0.16 on Accern’s scale. Accern also assigned media coverage about the company an impact score of 47.2996456656879 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.

Separately, Zacks Investment Research raised shares of R1 RCM from a “hold” rating to a “buy” rating and set a $4.00 target price for the company in a research note on Thursday, July 6th.

Shares of R1 RCM (NYSE:RCM) traded up 0.32% during mid-day trading on Friday, hitting $3.17. 247,683 shares of the stock traded hands. R1 RCM has a 52 week low of $1.75 and a 52 week high of $4.37. The stock has a 50-day moving average of $4.48 and a 200-day moving average of $3.84.

R1 RCM (NYSE:RCM) last issued its quarterly earnings results on Wednesday, August 2nd. The company reported ($0.11) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.04) by $0.07. The firm had revenue of $99.40 million during the quarter, compared to analysts’ expectations of $91.95 million. R1 RCM had a negative net margin of 6.74% and a negative return on equity of 51.77%. On average, analysts predict that R1 RCM will post ($0.04) earnings per share for the current year.

ILLEGAL ACTIVITY WARNING: This piece of content was published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this piece of content on another website, it was illegally copied and republished in violation of US and international copyright & trademark laws. The legal version of this piece of content can be viewed at https://www.thecerbatgem.com/2017/08/20/r1-rcm-rcm-receiving-somewhat-favorable-news-coverage-analysis-shows.html.

About R1 RCM

R1 RCM Inc, formerly Accretive Health, Inc, is a provider of revenue cycle management (RCM) and physician advisory services (PAS) to healthcare providers. The Company is engaged in providing management services of revenue cycle operations for the United States-based hospitals and other medical services providers.

Receive News & Stock Ratings for R1 RCM Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for R1 RCM Inc and related stocks with our FREE daily email newsletter.